JEFFREY KAUFFMAN: Open Payments
NPI 1235161282 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 12 payments from 8 companies in 2025. Trend: 2023 $812 · 2024 $631 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Ethicon US, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
| INTUITIVE SURGICAL, INC. | 1 | $13 |
Products named: Auvelity, CAPLYTA, INGREZZA, AUSTEDO XR, COBENFY, STRATAFIX, ABILIFY ASIMTUFII, Da Vinci Surgical System.
Industry payments across IN — which companies pay providers there.
